News & Media
Newsroom
clinical
Founder presents FMT in ALS at the 5th Greater Bay Area Brain Science Forum
Our founder, Dr. Li Xiaozheng, delivered a keynote on FMT research progress and clinical directions in ALS (amyotrophic lateral sclerosis).
company
JCY Bio named to Shenzhen's special-items import/export pilot whitelist
One of only five pharma-category companies in Shenzhen on the 2025 special biomedical items pilot whitelist — enabling cross-border research collaboration and microbiome-drug internationalization.
company
JCY Bio at Shenzhen International Biomedical Industry Summit
Invited to the 2023 Shenzhen Biomedical Industry Week; the team presented and introduced the FMT 3.0 Pro capsule.